Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alkem Laboratories Ltd.
NSE: ALKEM
|
BSE: 539523
|
ISIN: INE540L01014
|
Industry: Pharmaceuticals
Dividend
|
Mid-range Performer
4871.0000
-50.00
(
-1.02
%)
NSE
Aug 06, 2025
15:31 PM
Volume:
141.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alkem Laboratories Ltd.
10 Feb 2024
Dividend
4871.00
-1.02%
Alkem Labs (SELL): Good quarter; cut to SELL on stretched valuations
Sell:
Alkem Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 4800
Recommendation
Target
BOB Capital Markets Ltd.
Revenue grew 9% YoY in Q3 backed by strong India and ROW growth that offset lower US business
Number of FII/FPI investors increased from 535 to 551 in Jun 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended
Market closes lower, Lupin's Q1 net profit surges 52.1% YoY to Rs 1,219 crore
Trendlyne Marketwatch |
06 Aug 2025, 03:56PM
Five stocks to buy from analysts this week - August 6, 2025
The Baseline |
06 Aug 2025, 10:55AM
Alkem Laboratories hopes to fire up its US business to fuel future growth
|
02 Jul 2021